Emerging oral drugs for multiple sclerosis

Taylor and Francis Group, Expert Opinion on Emerging Drugs, 3(13), p. 465-477, 2008

Journal article published in 2008 by Claudio Gasperini

, Carlo Pozzilli

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by